For example, cetuximab is an anti-epidermal growth factor receptor (EGFR) monoclonal antibody approved for treating head and neck squamous cell carcinoma (HNSCC) and metastatic colorectal cancer. Here, EGFR is linked to head and neck squamous cell carcinoma.